1 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of zanubrutinib in the NHS in England.

Zanubrutinib is not recommended for the treatment of adults with chronic lymphocytic leukaemia.

Read NICE draft guidance consultation